Flora Growth (FLGC) Competitors $0.51 -0.08 (-13.32%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.54 +0.03 (+4.90%) As of 08/1/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FLGC vs. PDSB, IPSC, PYRGF, ATNM, RENB, ANL, CALC, PRLD, KALA, and CGTXShould you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include PDS Biotechnology (PDSB), Century Therapeutics (IPSC), PyroGenesis Canada (PYRGF), Actinium Pharmaceuticals (ATNM), Renovaro (RENB), Adlai Nortye (ANL), CalciMedica (CALC), Prelude Therapeutics (PRLD), KALA BIO (KALA), and Cognition Therapeutics (CGTX). These companies are all part of the "pharmaceutical products" industry. Flora Growth vs. Its Competitors PDS Biotechnology Century Therapeutics PyroGenesis Canada Actinium Pharmaceuticals Renovaro Adlai Nortye CalciMedica Prelude Therapeutics KALA BIO Cognition Therapeutics PDS Biotechnology (NASDAQ:PDSB) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment. Do institutionals and insiders have more ownership in PDSB or FLGC? 26.8% of PDS Biotechnology shares are held by institutional investors. Comparatively, 36.0% of Flora Growth shares are held by institutional investors. 9.2% of PDS Biotechnology shares are held by company insiders. Comparatively, 12.6% of Flora Growth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has preferable valuation and earnings, PDSB or FLGC? Flora Growth has higher revenue and earnings than PDS Biotechnology. PDS Biotechnology is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPDS BiotechnologyN/AN/A-$37.61M-$0.94-1.16Flora Growth$59.51M0.19-$15.91M-$0.98-0.52 Do analysts recommend PDSB or FLGC? PDS Biotechnology currently has a consensus target price of $9.00, indicating a potential upside of 725.69%. Flora Growth has a consensus target price of $4.00, indicating a potential upside of 684.31%. Given PDS Biotechnology's stronger consensus rating and higher possible upside, equities research analysts plainly believe PDS Biotechnology is more favorable than Flora Growth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PDS Biotechnology 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Flora Growth 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has more volatility and risk, PDSB or FLGC? PDS Biotechnology has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.97, indicating that its stock price is 97% more volatile than the S&P 500. Does the media prefer PDSB or FLGC? In the previous week, Flora Growth had 5 more articles in the media than PDS Biotechnology. MarketBeat recorded 5 mentions for Flora Growth and 0 mentions for PDS Biotechnology. PDS Biotechnology's average media sentiment score of 0.00 beat Flora Growth's score of -0.28 indicating that PDS Biotechnology is being referred to more favorably in the media. Company Overall Sentiment PDS Biotechnology Neutral Flora Growth Neutral Is PDSB or FLGC more profitable? PDS Biotechnology has a net margin of 0.00% compared to Flora Growth's net margin of -24.85%. PDS Biotechnology's return on equity of -150.59% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets PDS BiotechnologyN/A -150.59% -69.15% Flora Growth -24.85%-216.49%-45.56% SummaryPDS Biotechnology and Flora Growth tied by winning 8 of the 16 factors compared between the two stocks. Get Flora Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGC vs. The Competition Export to ExcelMetricFlora GrowthMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.28M$10.40B$5.49B$9.54BDividend YieldN/A1.99%4.73%4.09%P/E Ratio-0.5218.4228.8323.83Price / Sales0.1929.01372.0766.02Price / CashN/A22.3135.4557.96Price / Book1.653.478.275.54Net Income-$15.91M$234.77M$3.25B$259.28M7 Day Performance-17.13%-4.82%-3.73%-4.68%1 Month Performance-14.23%1.80%4.29%4.36%1 Year Performance-44.69%-12.51%25.87%17.88% Flora Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGCFlora Growth2.5539 of 5 stars$0.51-13.3%$4.00+684.3%-48.5%$13.28M$59.51M-0.52280News CoverageEarnings ReportGap DownHigh Trading VolumePDSBPDS Biotechnology1.6477 of 5 stars$1.18flat$9.00+662.7%-66.3%$53.94MN/A-1.2620IPSCCentury Therapeutics3.4069 of 5 stars$0.64+2.3%$4.20+556.3%-74.6%$53.90M$6.59M-2.21170Positive NewsGap DownHigh Trading VolumePYRGFPyroGenesis Canada0.3783 of 5 stars$0.29-2.9%N/A-53.5%$53.85M$9.14M-4.7990News CoverageGap UpHigh Trading VolumeATNMActinium Pharmaceuticals1.9786 of 5 stars$1.72-3.9%$4.00+132.6%-75.6%$53.66MN/A-1.2430News CoveragePositive NewsRENBRenovaro0.9438 of 5 stars$0.32+2.1%N/A-63.1%$53.17MN/A-0.4120Gap UpHigh Trading VolumeANLAdlai Nortye1.7682 of 5 stars$1.42-1.7%$9.00+536.0%-56.8%$53.14MN/A0.00127Upcoming EarningsCALCCalciMedica2.9898 of 5 stars$3.71-2.4%$16.00+331.3%-34.4%$53.09MN/A-2.3830PRLDPrelude Therapeutics3.2726 of 5 stars$0.85-8.4%$4.50+428.1%-85.3%$52.51M$7M-0.50120High Trading VolumeKALAKALA BIO3.5078 of 5 stars$7.93-2.0%$13.00+63.9%+19.4%$52.20M$3.89M-0.9630Upcoming EarningsCGTXCognition Therapeutics2.4049 of 5 stars$0.72-14.9%$2.83+296.2%-25.8%$52.07MN/A-0.9720Upcoming EarningsShort Interest ↑Gap Down Related Companies and Tools Related Companies PDSB Competitors IPSC Competitors PYRGF Competitors ATNM Competitors RENB Competitors ANL Competitors CALC Competitors PRLD Competitors KALA Competitors CGTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGC) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flora Growth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Flora Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FLGC Stock Alerts